Abstract: A tablet cooling device includes a copper plate, having a fan mounted on the coper plate to direct airflow; a heat sink secured directly under the fan; a thermal control board to control and regulate the fan and heat sink; and a peltier cooler secured underneath the heat sink; a sub cooling plate, having a circulation channel embedded in the sub cooling plate; a liquid mixture is circulated through the circulation channel; a power source; the thermal control board detects temperature to maintain a predetermined temperature range via active and passive cooling.

Abstract: A tablet cooling device includes a copper plate, having fans mounted on the copper plate to direct airflow; heat sinks secured directly under the fans; a thermal control board to control and regulate the fans and heat sinks; and peltier coolers secured underneath the heat sinks; a sub cooling plate, having a circulation channel embedded in the sub cooling plate; a liquid mixture is circulated through the circulation channel; a power source; the thermal control board detects temperature to maintain a predetermined temperature range via active and passive cooling.

Abstract: Methods of treating migrainous headaches and their associated symptoms are provided by administering a composition comprising parthenolide or feverfew sublingually to a patient in need thereof. Treatments are surprisingly effective with low total administered amounts of parthenolide or feverfew. Compositions and unit dose systems are also described.

Abstract: Methods of treating migrainous headaches and their associated symptoms are provided by administering a composition comprising parthenolide or feverfew transdermally to a patient in need thereof. Treatments are surprisingly effective with low total administered amounts of parthenolide or feverfew. Compositions and transdermal administration patches are also described.

Abstract: An improved method for administering parthenolide and/or feverfew extract as a dietary supplement is provided, wherein a dietary supplemental amount of parthenolide in a predetermined dosage amount of at least about 1 mg of parthenolide is transdermally administered to a patient. Transdermal delivery systems are also provided.

Abstract: Methods of treating migrainous headaches and their associated symptoms are provided by administering a composition comprising parthenolide or feverfew sublingually to a patient in need thereof. Treatments are surprisingly effective with low total administered amounts of parthenolide or feverfew. Compositions and unit dose systems are also described.

Abstract: An improved method for administering parthenolide and/or feverfew extract as a dietary supplement is provided, wherein an oral dosage composition comprising a dietary supplemental amount of parthenolide in a predetermined dosage amount of at least about 0.05 mg of parthenolide is orally administered to a patient. At least a portion of the administered oral dosage composition is retained by the patient in the oral cavity for a time sufficient to allow absorption of parthenolide by oral mucosal tissues. Compositions particularly suitable for oral mucosal administration of a parthenolide dietary supplement are also provided.

Abstract: In a can body maker apparatus including ram means for the forming of a can body mounted for reciprocal motion within a can body maker frame, an improved pressurized air delivery system is incorporated into the ram system to accomplish the air strip of the formed can body.